Suppr超能文献

促黄体生成素释放激素在生殖功能障碍诊断和治疗中的现状

Current status of luteinizing hormone-releasing hormone in diagnosis and treatment of disorders in reproductive function.

作者信息

Mahesh V B

出版信息

J Reprod Med. 1975 Oct;15(4):145-51.

PMID:765458
Abstract

The concept of the hypothalamic regulation of the function of the anterior pituitary was established by experiments involving the interruption of blood supply from the hypothalamus to the pituitary, transplantation of pituitary to sites away frm the hypothalamus and the effects of various lesion and electrical stimulation experiments with the hypothalamus. These experiments were the result of the concept proposed by Harris in 1937 that the pituitary gland may be controlled by the brain through substances carried to it by the portal vessels arising in the hypothalamus. The first direct evidence of the presence of a hypothalamic factor that could bring about the release of pituitary LH was provided independently in 1960 by McCann and co-workers and in 1961 by Harris and co-workers. The releasing factors and their physiological role was a subject of great interest, and porcine LH-RH was isolated by Schally et al. in 1971, followed by the isolation of ovine LH-RH by Guilleman and co-workers. The structure of the releasing factor has been established with no species differences between the ovine and porcine preparation and the decapeptide which has been synthesized. The use of LH-RH on various experimental animals has been done extensively, and evidence of the release of both LH and FSH has been obtained. In the absence of concrete evidence for a separate FSH-RH at this time, the above observation has led to the speculation that there is a single releasing factor that brings about the release of both FSH and LH. Both natural hormone from either ovine or porcine origin and the synthetic decapeptide have biological activity in the human. However, the rhesus monkey seems to be much less sensitive, and the question of a species difference has been raised. This subject has been reviewed in considerable detail by Schally and co-workers.

摘要

下丘脑对腺垂体功能调节的概念是通过一系列实验确立的,这些实验包括中断下丘脑到垂体的血液供应、将垂体移植到远离下丘脑的部位,以及对下丘脑进行各种损伤和电刺激实验。这些实验是基于哈里斯在1937年提出的概念,即垂体可能受大脑通过下丘脑产生的门脉血管携带的物质所控制。1960年,麦肯及其同事以及1961年哈里斯及其同事分别独立提供了下丘脑因子存在的首个直接证据,该因子可促使垂体释放促黄体生成素(LH)。释放因子及其生理作用成为了人们极大关注的课题,1971年沙利等人分离出了猪促性腺激素释放激素(LH - RH),随后吉勒曼及其同事分离出了羊促性腺激素释放激素。已确定释放因子的结构,羊和猪的制剂以及合成的十肽之间不存在种属差异。促性腺激素释放激素在各种实验动物上的应用已广泛开展,并获得了促黄体生成素和促卵泡生成素(FSH)均被释放的证据。鉴于目前尚无单独的促卵泡生成素释放激素(FSH - RH)的确切证据,上述观察结果引发了一种推测,即存在一种单一的释放因子可促使促卵泡生成素和促黄体生成素均被释放。来自羊或猪的天然激素以及合成的十肽在人体内均具有生物活性。然而,恒河猴似乎敏感性低得多,种属差异的问题由此被提出。沙利及其同事已对该课题进行了相当详细的综述。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验